CPYPP

Research use only, not for human use.

CPYPP is an inhibitor of DOCK2-Rac1 interaction. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2DHR-2 for Rac1 in a dose-dependent manner(IC50 : 22.8 μM).

CPYPP is an inhibitor of DOCK2-Rac1 interaction. CPYPP binds to DOCK2 DHR-2 domain and inhibits the guanine nucleotide exchange factor (GEF) activity of DOCK2DHR-2 for Rac1 in a dose-dependent manner(IC50 : 22.8 μM). CPYPP also inhibits DOCK180, DOCK5 and less DOCK9CPYPP as a small-molecule inhibitor of DOCK2.?CPYPP bound to DOCK2 DHR-2 domain in a reversible manner and inhibited its catalytic activity in vitro.?When lymphocytes were treated with CPYPP, both chemokine receptor- and antigen receptor-mediated Rac activation were blocked, resulting in marked reduction of chemotactic response and T cell activation.?These results provide a rational of and a chemical scaffold for development of the DOCK2-targeting immunosuppressant.

——

——

——

Others

Other Targets

DOCK2-Rac1|DOCK180|DOCK5|DOCK9

——

——

310460-39-0

324.76

C18H13ClN2O2

>98% (HPLC)

DMSO : 23 mg/mL (70.82 mM; Need ultrasonic)

ClC1=CC=CC=C1C=CC=C1C(=O)NN(C1=O)C1=CC=CC=C1

——

(-20℃)

With Ice Pack

≥ 2 years